Patents by Inventor Carlos Estuardo Aguilar-Cordova

Carlos Estuardo Aguilar-Cordova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION GMCI AND ATRI CANCER TREATMENT
    Publication number: 20220218801
    Abstract: Disclosed are methods of treating a cancer in a subject, comprising treating the subject with a combination of gene-mediated cytotoxic immunotherapy and a DNA damage response inhibitor.
    Type: Application
    Filed: March 30, 2022
    Publication date: July 14, 2022
    Inventors: Carlos Estuardo Aguilar-Cordova, Guzik Brian, Marilin Koch, Sean Lawler
  • GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER
    Publication number: 20220211783
    Abstract: Disclosed are methods of treating a cancer in a subject, comprising treating the subject with a combination of gene-mediated cytotoxic immunotherapy and an inhibitor of a DNA damage repair agent which is not ATR.
    Type: Application
    Filed: February 24, 2020
    Publication date: July 7, 2022
    Inventors: Carlos Estuardo Aguilar Cordova, Brian Guzik
  • Methods of cytotoxic gene therapy to treat tumors
    Patent number: 10350275
    Abstract: A method is disclosed for decreasing or retarding an increase in the size of a localized or metastatic tumor by using a combination of an immune stimulating cytotoxic gene therapy and immune-checkpoint modulating agent, in conjunction with other therapies, including radiation therapy, chemotherapy, surgery, and immunotherapies.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: July 16, 2019
    Assignee: Advantagene, Inc.
    Inventor: Carlos Estuardo Aguilar-Cordova
  • Methods of Cytotoxic Gene Therapy To Treat Tumors
    Publication number: 20150086541
    Abstract: A method is disclosed for decreasing or retarding an increase in the size of a localized or metastatic tumor by using a combination of an immune stimulating cytotoxic gene therapy and immune-checkpoint modulating agent, in conjunction with other therapies, including radiation therapy, chemotherapy, surgery, and immunotherapies.
    Type: Application
    Filed: September 19, 2014
    Publication date: March 26, 2015
    Inventor: Carlos Estuardo Aguilar-Cordova
  • Chemeric viral vectors for gene therapy
    Publication number: 20040086485
    Abstract: A nucleic acid sequence in a plasmid form comprising all the necessary elements for the production of a viral vector and this plasmid is delivered in-vivo with the intent of in-vivo viral vector production. The delivery of this vector may be further directed to specific targeted tissues by the addition of conjugated molecules, such as polycations, peptides, antibodies, single chain antibodies or combinations of the above.
    Type: Application
    Filed: October 4, 2002
    Publication date: May 6, 2004
    Inventor: Carlos Estuardo Aguilar-Cordova